| Financial Year |
March 31 2023 |
| Monetary Funds |
6,738,412,212.41 |
| Held-for-trading Financial Assets |
1,250,000,000.00 |
| Notes Receivable |
3,176,295.66 |
| Accounts Receivable |
523,898,699.49 |
| Advances to Suppliers |
41,911,456.78 |
| Other Receivables |
10,929,782.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
340,793,569.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
120,249,075.40 |
| Other Current Assets |
115,592,227.13 |
| Total Current Assets |
9,144,963,319.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
272,147,725.41 |
| Long-term Equity Investment |
732,622,988.23 |
| Investment Properties |
20,186,804.00 |
| Fixed Assetes |
4,039,789,004.85 |
| Under-construction Projects |
581,096,990.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
278,278,205.65 |
| R&D expenses |
32,198.07 |
| Goodwill |
1,295,475.11 |
| Long-Term Deferred and Prepaid Expenses |
10,680,426.83 |
| Deferred Income Tax Assets |
13,335,898.99 |
| Other Non-Current Assets |
121,043,036.64 |
| Sub-Total of Non-Current Assets |
6,935,033,011.01 |
| Total Assets |
16,079,996,330.50 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
457,434,324.53 |
| Accounts Received In Advance |
80,760,339.60 |
| Employee Compensation Payable |
187,889,461.78 |
| Taxes Payable |
6,961,044.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,853,742.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
125,813,396.13 |
| Other Current Liabilities |
7,770,626.93 |
| Sub-Total of Current Liabilities |
1,783,320,697.22 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
720,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
91,164,740.82 |
| Sub-Total of Non-Current Liabilities |
1,254,423,239.30 |
| Total Liabilities |
3,037,743,936.52 |
| Paid-In Capital(Or Share Stock) |
1,391,777,884.00 |
| Capital Surplus |
6,555,503,743.28 |
| Surplus Reserve |
995,832,571.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,099,138,195.34 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,042,252,393.98 |
| Owner's Equity（Stockholder's Equity） |
13,042,252,393.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,079,996,330.50 |
